Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines

20 Dec 2004

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Endoplasmic Reticulum Stress and Disease
Share to Genomics, phytochemicals, and oxidative stress

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15608674
DOI: 10.1038/sj.onc.1208313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell linesPMID 15608674Read ↗

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer CellsSemantic proximity Read ↗

Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells.Semantic proximity Read ↗

Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell lineSemantic proximity Read ↗

ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-ĸB/CD44 pathway in urinary bladder carcinomaSemantic proximity Read ↗

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell linesSemantic proximity Read ↗

The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancerSemantic proximity Read ↗

Identification and Validation of a Novel Prognostic Model Based on Platinum Resistance-Related Genes in Bladder CancerSemantic proximity Read ↗

Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.